1-10 of 10
Weili Zhao, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

Free
Gang An, MD PhD, Daobin Zhou, MD PhD, Weili Zhao, MD PhD, Keshu Zhou, MD PhD, Jianyong Li, MD PhD, Jianfeng Zhou, MD PhD, Liping Xie, MD PhD, Jie Jin, MD PhD, Liye Zhong, MD PhD, Lingzhi Yan, MD PhD, Haiyi Guo, MD, Chenmu Du, MD, Jane Huang, MD, William Novotny, MD, Jinhua Zhong, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-136783
Published: 2020
Journal Articles

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Free
Constantine S. Tam, MBBS, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, Gareth P Gregory, MBBS (Hons), PhD FRACP, FRCPA, Aichun Liu, MD, Anna M. Johnston, Weili Zhao, MD PhD, Fernando Roncolato, BMed, FRACP, FRCPA, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS (Hons), MD FRACP, FRCPA, AFRCMA, MACD, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Wenyu Li, MD PhD, Ted Shih, PharmD, Xiaoping Zhang, MD MS, Ken Wu, PhD, Yuan Liu, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 1594.
https://doi.org/10.1182/blood-2019-125485
Published: 2019
Journal Articles

Clinical Response in Relapsed/Refractory (R/R) B-NHL Treated with the CD19-Directed CAR T-Cell Product JWCAR029

Free
Zhitao Ying, MD PhD, Pengpeng Xu, MD, Li Wang, MD PhD, Shu Cheng, MD PhD, Wen Wu, MD PhD, Wen Wang, MD PhD, Ming Hao, PhD, Su Yang, Harry Lam, PhD, James Li, Hongxia Zheng, MD PhD, Weili Zhao, MD PhD, Yuqin Song, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2876.
https://doi.org/10.1182/blood-2019-127751
Published: 2019
Journal Articles

Serum microRNA Prognostic Model and Underlying Immune Alterations in Diffuse Large B Cell Lymphoma

Free
Sun Rui, MD, Weili Zhao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5225.
https://doi.org/10.1182/blood-2019-128008
Published: 2019
Journal Articles

A Phase II Study of Lenalidomide Plus Rituximab in Patients with Newly Diagnosed Follicular Lymphoma: An Interim Analysis

Free
Zhong Zheng, Li Wang, MD PhD, Shu Cheng, Pengpeng Xu, Weili Zhao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3984.
https://doi.org/10.1182/blood-2019-126667
Published: 2019
Journal Articles

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients in China in the Rituximab Era

Free
Yun Li, MD PhD, Meng Wu, MD, Huiqiang Huang, MD PhD, Wei Xu, MD PhD, Haiwen Huang, MD PhD, Weili Zhao, MD PhD, Yanyan Wang, MD, Shuo Liu, MD, Pengpeng Xu, MD, Zhengming Chen, Yuqin Song, MD PhD, Jia Ruan, MD PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3994.
https://doi.org/10.1182/blood-2019-125192
Published: 2019
Journal Articles

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Free
Sang Eun Yoon, Seok Jin Kim, MD PhD, Tsai-Yun Chen, MD, Yong Park, Li Mei Poon, MBBS, MRCP, FRCPath, Young Rok Do, PhDMD, Ho Sup Lee, MD PhD, Won Sik Lee, MD PhD, Hong-ghi Lee, MD PhD, Soon Thye Lim, MBBS, MRCP, Hye Jin Kang, MD PhD, Cosphiadi Irawan, Jae Joon Han, MD PhD, Hyo Jung Kim, MD PhD, Cheolwon Suh, Hwan Jung Yun, MD, Soo Chin Ng, FRCP, Jae-Cheol Jo, MD PhD, Byeong Seok Sohn, MD PhD, Sung Yong Oh, Yeung-Chul Mun, MD, Daryl Tan, MBBS, MRCP, Seong Kyu Park, MD, Jae-Yong Kwak, MD PhD, Ye Guo, MD PhD, Huilai Zhang, MD, Jun Zhu, MD PhD, Weili Zhao, MD PhD, Won Seog Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4035.
https://doi.org/10.1182/blood-2019-126637
Published: 2019
Journal Articles

Cellular Kinetics and Anti-Therapeutic Antibody in Relapsed/Refractory B-NHL Patients Treated with JWCAR029

Free
Zhitao Ying, MD PhD, Pengpeng Xu, MD, Ming Hao, PhD, Li Wang, MD PhD, Shu Cheng, MD PhD, Wen Wu, MD PhD, Wen Wang, MD PhD, Zisong Zhou, Su Yang, Jennifer Wang, PhD, Harry Lam, PhD, James Li, Hongxia Zheng, MD PhD, Weili Zhao, MD PhD, Yuqin Song, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4083.
https://doi.org/10.1182/blood-2019-126408
Published: 2019
Journal Articles

Retinoic Acid and Arsenic Trioxide with or without Chemotherapy for Acute Promyelocytie Leukemia with Different Risk Stratifications: A Interim Analysis of China APL 2012 Study

Free
Junmin Li, Prof., Li Chen, Hongming Zhu, Jiong Hu, PhD/MD, Bing Chen, Xiaoyang Li, Lining Wang, Yunxiang Zhang, Yuhong Ren, Huijin Zhao, Yu Chen, Huiping Sun, Qiusheng Chen, Yu Chen, Weili Zhao, MD PhD, Jianqing Mi, Zhixiang Shen, MD, Zhenyi Wang, Zhu Chen, Saijuan Chen
Journal: Blood
Blood (2016) 128 (22): 445.
https://doi.org/10.1182/blood.V128.22.445.445
Published: 2016
Journal Articles

Somatic Mutations of Epigenetic Regulator Genes in Diffuse Large B-Cell Lymphoma

Free
Yao-hui Huang, Weili Zhao, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1756.
https://doi.org/10.1182/blood.V128.22.1756.1756
Published: 2016